Top news of the week: 22.08.2022.
Biotechnology
Hematology
Malaria
Cell nucleus
Red blood cell
Thalassemia
RT @adamfeuerstein: BREAKING --> Bluebird $BLUE wins U.S. approval for a gene therapy to treat patients with a rare blood disorder https://t.co/RuOaXr3qHX
OpenBluebird wins U.S. approval for a gene therapy to treat patients with a rare blood disorder
The FDA approved a new treatment that delivers a potentially permanent, genetic fix for patients with the inherited blood disorder beta thalassemia.